Theme: Latest challenges for the eradication of Rare Diseases

RARE DISEASES MEET 2022

RARE DISEASES MEET 2022

We gladly invite all participants from around the world to join the "9th International Conference on Rare Diseases & Orphan Drug," which will be held on April 13, 2022, Webinar. This conference is running around the theme: Latest challenges for the eradication of Rare Diseases. Scientists from industry and academia, as well as executives from healthcare providers, policymakers, industrialists, and investors, will gather at Europe Conferences to share unique insights into infectious disease research and development. Through exhibitions and oral talks by experts in the field, this event will also place a strong emphasis on international cooperation.

Rare Diseases Meet 2022 will be an excellent venue for exchanging new findings and ideas. It is a one-day programme that will grab the interest of attendees to learn more about Tropical and Infectious Diseases. Laboratory Professionals, Pathologists, Pathology Assistants, Scientists, Professors, Business Assistants, Students, and individuals from all medical societies and universities will be able to network at this event. It will be more efficient and both convenient to obtain quality information for various individual needs with the support of Keynote Speakers, Symposium, workshops, and exhibition.

Why to attend?

Rare Diseases Meet 2022 incredibly gives the best stage to the well-known speakers to give their talks about the most recent technique, system and the current updates in the dynamic field of infectious diseases. This stage rouses numerous youthful scientists to further develop their abilities and assist them with making new ideas in the area of bacterial infectious diseases. The key themes are talked about by the top famous speakers with worldwide acknowledgment from the world's best organizations.

Target Audience

  • Epidemiologists
  • Cardiologists
  • Neurologists
  • Ophthalmologists
  • Anesthesiologists
  • Bacteriologists
  • Microbiologists
  • Pathologists
  • Virologists
  • Infectious Diseases Specialists
  • Mycologists
  • Rare Disease Association
  • Orphan Drug Companies
  • Business Entrepreneurs and Industrialists
  • Medical Colleges
  • Drug Manufacturing Companies and Industries
  • Scientists
  • Students

 

TRACK 1: Coronavirus, SARS & MERS

Coronavirus disease (COVID-19) is a recent outbreak of an infectious disease. This disease is frequently passed down from one person to another, either directly or indirectly. The most common sign discovered in infected persons is metabolic disorders. Individuals over the age of 65, as well as those suffering from medical conditions like as depression, diabetes, chronic respiratory disease, and cancer, are more likely to be identified. The understanding of the COVID-19 virus should be trained in order to prevent the virus from interfering. Defend yourself and others from infection. Area unit should take three primary steps. Do not bite your face and wash your hands frequently with water or sanitise with an alcohol-based sanitizer. It's also critical that you practise metabolic hygiene and maintain social distance.

TRACK 2: Respiratory and Blood Infections

The morbidity of metabolic illnesses and blood infections accounts for 30-40% of the total. When a microorganism infection reaches the circulatory system through the lungs or skin, it causes blood infections or blood disorders. Based on the location of the receiving infection and hazard factors, BSI is frequently categorised as hospital-acquired or community-acquired. Germs that can infect the metabolic framework can spread through the secretion glands spit and secretion, which is also known as "respiratory secretions."

  • Sneezing
  • Muscle aches
  • Breathlessness
  • Tight chest or wheezing

TRACK 3:  Influenza Virus

Influenza is a contagious disease caused by the respiratory disorder virus. It is also known as respiratory illness. High temperature, runny nose, pharyngitis, muscle and joint discomfort, headache, coughing, and tiredness are the most common symptoms, which appear after a couple of days and can linger for weeks. The symptoms of "stomach flu" or the "24-hour flu" in children include loose bowels and ejection. Viral infections, secondary microorganism lung diseases, sinus infections, respiratory diseases, and coronary failure should all be included.

  • Sniffling
  • Aching
  • Coughing
  • Running high fevers

TRACK 4:  Infectious Diseases and Vaccines

Microorganisms are the most common cause of infectious illnesses. Pathogens come in a variety of forms, including viruses, bacteria, fungi, and parasites. These infectious diseases will spread from one person to another, through the environment, animal contact, or bug bites. The symptoms of many infectious disorders include fever, rash, diarrhoea, tiredness, and muscle aches. Through protection, vaccines prevent infectious diseases such as respiratory illness, diphtheria, viral hepatitis, measles, meningitis, serotype b infection, tetanus, rubella, and infectious disease. The communicable disease for which a vaccine-preventive immunogen exists is referred to as vaccine-preventable un-wellness. If a person contracts a vaccine-preventable illness and dies as a result of it, the death is considered a vaccine-preventable death.

  • Influenza
  • Measles

TRACK 5:  Drug Interaction in Infectious Diseases

Drug interactions in infectious diseases are a major source of medical harm that can be avoided. Patients are exposed to a high risk of drug interactions. Drug interactions provide a significant issue for patients and their care providers, according to the approved drug product labels for anti-infective medications, direct-acting antivirals for HCV, and HIV medications. Interactions could also be caused by non-CYP enzymes, CYP enzymes, and variations in stomachic pH, as well as the ever-growing list of drug transporters. Interactions caused by dietary components, flavouring drugs, and biological products are among the other problems.

  • Fluoxetine and Phenelzine
  • Digoxin and Quinidine
  • Warfarin and Diflunisal
  • Theophylline and Ciprofloxacin

TRACK 6:  Food Borne & Water Borne Infections

Foodborne illness is caused by consuming infected foods or beverages. Foodborne illnesses are caused by food pollutants, while biological dangers include bacteria, viruses, and parasites. Natural poisons and chemical pollutants are both examples of chemical risks. Metals, plastic goods, and broken glass will be physical hazards. Bacteria, bacteria, and viruses are the most common causes of these disorders. Waterborne diseases are caused by harmful microorganisms such as viruses and bacteria that are spread through water. These infections spread through bathing, washing, drinking, or eating food that has been exposed to polluted water.

  • Diarrhea
  • Nausea
  • Vomiting with or without fever

TRACK 7:  Neurological Infections

Infectious disorders that have been detected within the system are known as neurological infections. The most challenging neurologic infections are infectious agent and immune mediate illnesses of the system. Disseminated multiple sclerosis and HIV are the two most frequent neurologic illnesses. Despite significant advances in the treatment of infectious diseases, central nervous system (CNS) infections remain a substantial threat. They're typically difficult to diagnose, and the covers are either inadequate or non-existent. Acute and persistent infections will be distinguished. The meninges (meningitis) or the brain material itself (encephalitis) are the two types of infections that can affect the nervous system (meningoencephalitis). Some infections induce an inflammatory response that causes brain harm multiple times or at the same time as the illness. In some inflammatory disorders, additional problems may develop that are linked to the illness and gradually infect and reduce the activity of the central nervous system.

TRACK 8: STD (Sexually Transmitted Diseases) and Control

Sexually transmitted diseases are a condition that is conveyed from one person to another through sexual interaction (STD). It's caused by having an unprotected epithelial duct, anal, or sexual activity with someone who has the STD. Sexually transmitted infection (STI) or venereal disease (VD) is another term for sexually transmitted disease. STDs can also be spread through the sharing of needles and nursing. There are several types of STDs, including Chlamydia, HPV (human papillomavirus), girdle disease, and sexually transmitted illness, among others. HPV has been linked to cancers of the mouth, cervix, vulvar, and erectile organs.

TRACK 9: AIDS

HIV infection does not cause AIDS right away, and the details of how it does, as well as whether or not all HIV-positive patients will develop the disease, are still up for debate. Nonetheless, mounting evidence points to the virus's development in CD4 T cells and the immunological response to it as important puzzle pieces in the AIDS puzzle. HIV is a global epidemic, and despite significant progress in understanding the disease's pathophysiology and epidemiology, the number of infected persons continues to rise at an alarming rate, indicating that more people will die from AIDS in the coming years. According to WHO estimates, 16.3 million people have died as a result of AIDS since the pandemic began, and there are currently over 34.3 million people living with HIV infection, the majority of whom live in Sub-Saharan Africa, where approximately 7% of young adults are afflicted. Over 25% of people in several nations in this region, such as Zimbabwe and Botswana, are infected.

TRACK 10:  Orphan Diseases and Public Health

An orphan disease is a disease that is significantly more widespread in underdeveloped countries than in affluent countries according to US definition, a disease that affects fewer disregards such as cholera, typhoid, TB, and malaria. Basic science, epidemiology, behavioural research, clinical research, health care services, statistics, economics, and policy are all used by public health practitioners to identify the primary or secondary causes of health threats and then consistently prevent or reduce these causes in entire populations.

  • Cystic fibrosis
  • Lou Gehrig's disease
  • Tourette's syndrome
  • Duncan's Syndrome
  • Madelung's disease
  • Gigantism

TRACK 11: Neglected Rare Tropical Diseases

Neglected rare tropical diseases are a group of infectious diseases that affect 149 nations in the tropics and subtropics. Bacteria, parasites, helminths, fungi, protozoans, viruses, and other pathogens cause diseases that impact over one billion people and cost emerging economies billions of dollars each year. These, together with humour disease, river blindness, infection, and soil-transmitted infestation, as well as a variety of other neglected diseases, pose a substantial public health threat. They have an effect on populations living in poverty, particularly when there is a lack of proper hygiene, sanitation, and close contact with a variety of infectious vectors and diseases that affect livestock, and they cause significant health and financial burdens in underdeveloped countries, as well as having a wide impact on their socio-economic statuses. Unlike other public-health threats such as protozoal infection, infectious illness, infectious disease, Leprosy, protozoal infection, infection, Hookworm infection, and HIV, the weight of human suffering caused by neglected tropical diseases is underappreciated by the medical world.

  • Cysticercosis
  • Dengue Fever
  • Dracunculiasis (Guinea Worm Disease)
  • Echinococcosis

TRACK 12: Orphan Drugs- Development Trends and Strategies

A medicine that is used to treat an orphan disease is known as an orphan drug. Haem arginate, for example, is an orphan medication used to treat tiny cintermittent porphyria, variegate porphyria, and hereditary coproporphyria. A medicinal product known as an orphan drug is one that was created specifically to treat a rare medical ailment, which is referred to as a "orphan disease." It can be characterised as pharmaceuticals that are not developed by the pharmaceutical industry for financial reasons, but rather are developed in response to public demand.

  • Acute intermittent porphyria
  • Variegate porphyria
  • Haem arginate
  • Hereditary coproporphyria

TRACK 13: Paediatric Rare Diseases

Patients who are resistant to intravenous immunoglobulin (IVIG) treatment are at a higher risk of having their condition advance in an unfavourable way. There is minimal evidence that alternative treatments are beneficial in these patients. Biologicals such as interleukin-1 receptor blockers and tumour necrosis factor inhibitors are, however, becoming more often employed. If the patient does not respond to one of these therapies, a combination of two biologicals could be used instead, but this is not widely accepted due to the higher risk of infection.

  • Paediatric infectious
  • Intravenous Immunoglobulins

TRACK 14: Orphan Drugs Treatment for Rare Diseases

Medications developed expressly to treat rare disorders, known as "orphan drugs," are sometimes overlooked due to their high cost. On this day, it's worth revisiting a series of Healthcare Triage films we updated last year, which focuses mostly on orphan pharmaceuticals, what's wrong with the current system, and how we can get ridge out of it. Can we, as a people, get out of this system's worst situation? A medicine that is used to treat orphan diseases, such as heam arginate and others, is known as an orphan drug.

  • Acute intermittent porphyria
  • Variegate porphyria
  • Hereditary coproporphyria
  • Haem arginate

TRACK 15: Rare Bacterial, Viral and Fungal Infections

Fungal infections can readily impact people since the infection in the body grows faster as it spreads. Mild fungal skin illnesses, which might appear as a rash, are extremely prevalent. The symptoms of fungus in the lungs are quite similar to those of other disorders that cause fever, such as bacterial or viral pneumonia. Some fungal infections, such as fungal bloodstream infections and mucormycosis infections, can be fatal. Fingernails are the most common source of fungal infections, and because we rarely wash our hands, the infection spreads directly into our mouths.

  • Aspergillosis
  • Blastomycosis
  • Candidiasis
  • Coccidioidomycosis
  • Fungal Eye Infections

TRACK 16: Infection Control & Public Awareness

Infection management and public awareness are important to teach patients, families, visitors, and employees about human services-related infections, as well as what activities healthful services offices may have established to ensure that contaminations are countered but may moderately be expected, and what they'll do to prevent contaminations from spreading. Tending providers have a social responsibility to protect patients and prevent unnecessary damage. In critical situations needing rapid action, attending providers should assess the risk to the patient's life and select the most appropriate illness treatment strategy in those circumstances. The general population should be aware of the harm that will be caused if infectious illness treatment is neglected.

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 22-22, 2022
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View